{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:39:07Z","timestamp":1761766747989,"version":"3.40.5"},"reference-count":29,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T00:00:00Z","timestamp":1595030400000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Therapy"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1111\/dth.13613","type":"journal-article","created":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T11:14:50Z","timestamp":1589714090000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Labeled use of efinaconazole topical solution 10% in treating onychomycosis in children and a review of the management of pediatric onychomycosis"],"prefix":"10.1155","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8664-7723","authenticated-orcid":false,"given":"Aditya K.","family":"Gupta","sequence":"first","affiliation":[{"name":"Division of Dermatology, Department of Medicine University of Toronto  Toronto Ontario Canada"},{"name":"Mediprobe Research Inc.  London Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maanasa","family":"Venkataraman","sequence":"additional","affiliation":[{"name":"Mediprobe Research Inc.  London Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil H.","family":"Shear","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine University of Toronto  Toronto Ontario Canada"},{"name":"Department of Medicine (Dermatology, Clinical Pharmacology and Toxicology), Sunnybrook Health Sciences Centre  Toronto Ontario Canada"},{"name":"Department of Pharmacology Sunnybrook and Women's College Health Science Centre  Toronto Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Piguet","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine University of Toronto  Toronto Ontario Canada"},{"name":"Division of Dermatology, Department of Medicine Women's College Hospital  Toronto Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,7,18]]},"reference":[{"key":"e_1_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1177\/1203475417716362"},{"key":"e_1_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13677"},{"key":"e_1_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16394"},{"key":"e_1_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)80215-0"},{"key":"e_1_2_3_6_1","unstructured":"Valeant Pharmaceuticals. Jublia (Efinaconazole) Package Insert [Internet]. Drugs@FDA; 2014 [cited May 14 2020].http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/203567s000lbl.pdf(Revised 2020)."},{"issue":"7","key":"e_1_2_3_7_1","first-page":"815","article-title":"The efficacy and safety of efinaconazole 10% solution for treatment of mild to moderate onychomycosis: a pooled analysis of two phase 3 randomized trials","volume":"13","author":"Gupta AK","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00111-14"},{"key":"e_1_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2015.1034081"},{"issue":"11","key":"e_1_2_3_10_1","first-page":"1388","article-title":"Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails","volume":"13","author":"Sakamoto M","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_3_11_1","doi-asserted-by":"crossref","unstructured":"EichenfieldLF ElewskiB SugarmanJ et al. Safety pharmacokinetics and efficacy of efinaconazole 10% topical solution for the treatment of onychomycosis in pediatric patients. 2020 Maui Derm for Dermatologists Annual Meeting;2020.","DOI":"10.36849\/JDD.2020.5401"},{"key":"e_1_2_3_12_1","doi-asserted-by":"crossref","unstructured":"EichenfeldLF ElewskiBE SugarmanJL et al.Efinaconazole 10% topical solution for the treatment of onychomycosis in pediatric patients: open\u2010label phase 4 study;2020.","DOI":"10.1016\/j.jaad.2020.06.1004"},{"key":"e_1_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.10.013"},{"key":"e_1_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/pde.13561"},{"issue":"2","key":"e_1_2_3_15_1","first-page":"105","article-title":"Pediatric onychomycosis: the emerging role of topical therapy","volume":"16","author":"Eichenfield LF","year":"2017","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.1998.tb01396.x"},{"key":"e_1_2_3_17_1","unstructured":"Novartis Pharmaceuticals. Lamisil (terbinafine hydrochloride) Oral Granules Package Insert [Internet]. Drugs@FDA; 2017 [cited May 28 2020].https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/020539s029 022071s013lbl.pdf."},{"key":"e_1_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.4483"},{"key":"e_1_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.1177\/1203475417733461"},{"key":"e_1_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.0093"},{"key":"e_1_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/pde.12064"},{"key":"e_1_2_3_22_1","unstructured":"Aventis Pharmaceuticals Inc. Penlac\u00ae Nail Lacquer (ciclopirox) Topical Solution 8% [Internet]. Drugs@FDA; 2004 [cited 2013 Mar 15].http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2004\/21022s004lbl.pdf."},{"key":"e_1_2_3_23_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.109071"},{"issue":"2","key":"e_1_2_3_24_1","first-page":"190","article-title":"Tavaborole 5% topical solution for the treatment of toenail Onychomycosis in pediatric patients: results from a phase 4 open\u2010label study","volume":"18","author":"Rich P","year":"2019","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_3_25_1","unstructured":"PharmaDerm. KERYDIN (tavaborole) topical solution [Internet]. Drugs@FDA; 2018 [cited May 28 2020].https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/204427s006lbl.pdf."},{"key":"e_1_2_3_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)90065-1"},{"issue":"6","key":"e_1_2_3_27_1","first-page":"7","article-title":"Update on efinaconazole 10% topical solution for the treatment of onychomycosis","volume":"21","author":"Gupta AK","year":"2016","journal-title":"Skin Therapy Lett"},{"key":"e_1_2_3_28_1","doi-asserted-by":"publisher","DOI":"10.7547\/14-088"},{"key":"e_1_2_3_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13358"},{"key":"e_1_2_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)80142-3"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdth.13613","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dth.13613","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dth.13613","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dth.13613","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T17:57:07Z","timestamp":1671818227000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dth.13613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1111\/dth.13613"],"URL":"https:\/\/doi.org\/10.1111\/dth.13613","archive":["Portico"],"relation":{},"ISSN":["1396-0296","1529-8019"],"issn-type":[{"type":"print","value":"1396-0296"},{"type":"electronic","value":"1529-8019"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"2020-05-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}